Oncolytic Viruses as Cancer Therapeutic Conference
Phase I-II clinical trial results with JX-594, a targeted
2008년도 제 2차 한국유전자치료학회, 서울대학교병원 어린이병원 1층 임상강의실
Correlation between body temperature, blood pressure, cytokines, Nab and viral replication after oncolytic virus(JX-594) intratumoral injection in phase 1/2 clinical trial
14th Annual Meeting of JSGT
Conbinational therapy with JX-594 Oncolytic vaccinia virus and sorafenib(Nexavar)in human hepatocellular cancer cell lines
부산대학교병원 임상시험센터 & 한국유전자치료학회 공동심포지움
Clinical Application of Virotherapy, collaboration strategy for early phase of clinical study
제60차 대한약리학회 추계학술대회
USE OF TARGETED ONCOLYTIC POXVIRUS, JX-594, IN PATIENTS WITH REFRACTORY PRIMARY OR METASTATIC LIVER CANCER